Nugget of biotech company news in my latest cover for the @BosBizJournal: Daniel Fischer and former Genzyme co-founder Harvey Lodish will be launching a new company called Tevard Biosciences soon.https://twitter.com/bosbizallison/status/1223256757033734145 …
-
Founders I spoke to acknowledged it’s difficult to get VC money. But the standing questions seem to be where else they can get money to make these drugs, many of which are gene therapies/are there other viable options?
Everyone is obsessed with gene therapy as the one and only Hail Mary pass and that’s driving the multi-year wait times and multi-million dollar price tags. Vector manufacturing supply chain is not built for n-of-1. Families pooling $ to build agile vector manufacturing is next..
